ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal.

August 13, 2004

Secret Budget Sessions Ended; HEW Out To Lim. Future NCI Funds

April 2, 1976

Burton’s Clinic Reopens; Some Insurers Reportedly Reimbursing; New York Congressman Calls For Evaluation

March 28, 1986

Hospitals Win Grants For Radiation Oncology Disparity Research.

January 3, 2003

HPV Vaccines Should Be Priority, Say President’s Cancer Panel

March 7, 2014

Gallo Wins Another, To Share Hammer Prize With Three Japanese

November 30, 1984